Prawo i regulacje · 14/02/2005

DEA Proposes Zopiclone Placement in Schedule IV of Controlled Substances Act

The Drug Enforcement Administration (DEA) has proposed placing the substance zopiclone, including its salts and isomers, into Schedule IV of the Controlled Substances Act (CSA), following a recommendation from the Acting Assistant Secretary for Health of the Department of Health and Human Services (DHHS) and an evaluation of relevant data by the DEA.